Podcast Hub

Latest Episodes

Registry Insider 

Episode 89: Meet The EMS Research Fellows!

The future of EMS depends on research that drives better decisions, stronger systems, and improved patient care. In this episode of Registry Insider, host Bill Seifarth sits down with the National Registry's three current EMS Research Fellows to discuss their journeys into research, the groundbreaking projects they're leading, and how the fellowship is shaping the next generation of EMS scientists. From workforce resilience and cardiac arrest research to airway management and public health, the conversation offers an inside look at how research is helping advance the EMS profession. The fellows also share what it's like to balance doctoral studies with full-time work at the National Registry, the value of mentorship, and the unique opportunities the fellowship provides. Whether you are an EMS clinician, educator, leader, or someone passionate about the future of prehospital care, this episode offers an inspiring look at the people and research driving the profession forward. To learn more about the National Registry EMS Research Fellowship and upcoming application opportunities, visit NREMT.org.

Watch on YouTube

Listen on Buzzsprout


From Science to the Scene

Rethinking Seizure Management in the Field

Generalized, convulsive status epilepticus is a critical emergency where time and proper treatment matter immensely. In the latest episode of From Science to the Scene, Jacob breaks down a national study published in Annals of Emergency Medicine evaluating real-world midazolam use across 657 EMS agencies. National guidelines recommend a single 10 mg intramuscular (IM) injection for seizing adults, yet guideline-concordant care occurred in only 4.1% of the encounters. Most patients received lower doses via intravenous (IV) or intranasal (IN) routes.
Additionally, dosing and route directly impacted patient outcomes!
  • Route: IN midazolam had the highest first dose failure rate frequently requiring rescue medication.
  • Dose: Higher midazolam doses improved seizure control without increasing the need for ventilatory support.
For field Clinicians, these findings reinforce the risks of underdosing and show that decisive administration of 10 mg midazolam IM or rapid IV administration, if feasible, remain safe and highly effective vs IN delivery while on scene.

Watch on YouTube

Listen on Buzzsprout




Inside The Podcasts

Registry Insider 

Hosted by CEO Bill Seifarth, Registry Insider brings you insight, news, and in-depth conversations on topics shaping the National Registry and the EMS profession. New episodes drop on Tuesdays. Click for the latest episode and more. Watch on our YouTube channel or the National Registry website.

Checkout All Episodes

From Science to the Scene

Produced by the National Registry’s Research Team, From Science to the Scene bridges the gap between academic research and field medicine, translating complex data from the American Heart Association (AHA), the Prehospital Guidelines Consortium (PGC), and leading journals into actionable knowledge for EMS Clinicians and leaders. 

Checkout All Episodes